Sfoglia per AUTORE
PANE F
Collezione AOU Novara

  

Items : 15

Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. in Hematological oncology / Hematol Oncol. 2024 Jan;42(1):e3216. doi: 10.1002/hon.3216. Epub 2023 Sep 29.
2024
AOU Città della Salute di Torino
AOU Novara

Malgieri S; Molica S; Iannella E; Gozzetti A; Reda G; Caira M; Finsinger P; Gualberti G; Zamprogna G; Coscia M; Albano F; Trentin L; Vallisa D; Pane F; Cuneo A; Mauro FR; Albi E; Chiarenza A; Gaidano G; Sportoletti P; Laurenti L;

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes. in Annals of hematology / Ann Hematol. 2024 Feb;103(2):437-442. doi: 10.1007/s00277-023-05577-9. Epub 2023 Dec 7.
2024
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Vannucchi AM; Finazzi MC; Tognoni G; Cattaneo D; Vianelli N; Bellini M; Scaffidi L; Bucelli C; Ramundo F; Lunghi F; Betti S; Gesullo F; Guglielmelli P; Mora B; Cacciola E; Calabresi L; Loscocco GG; Rumi E; Patriarca A; Cascavilla N; Siragusa S; Musolino C; Carli G; Caramella M; Rapezzi D; Ricco A; Pane F; Benevolo G; et alii...

Parsaclisib for the treatment of primary autoimmune hemolytic anemia: Results from a phase 2, open-label study. in American journal of hematology / Am J Hematol. 2024 Dec;99(12):2313-2320. doi: 10.1002/ajh.27493. Epub 2024 Oct 22.
2024
AOU Novara

Rappold E; Leopold L; Hanna WT; DeSancho MT; Terriou L; Murakhovskaya I; Patriarca A; Pane F; Barcellini W; Szeto K; Wei S; Jäger U;

Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera. in NEJM evidence / NEJM Evid. 2023 Jun;2(6):EVIDoa2200335. doi: 10.1056/EVIDoa2200335. Epub 2023 May 15.
2023
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Tognoni G; Bellini M; Finazzi MC; Bucelli C; Vianelli N; Lunghi F; Scaffidi L; Betti S; Gesullo F; Guglielmelli P; Loscocco GG; Mannarelli C; Cacciola E; Mora B; Cascavilla N; Rumi E; Patriarca A; Musolino C; Siragusa S; Carli G; Caramella M; Rapezzi D; Pane F; Ricco A; Benevolo G; Iurlo A; Palandri F; Bonifacio M; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.
2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Della Porta MG; Santini V; Naldi I; Finelli C; Sancetta R; Selleri C; Pasini P; Giordano L; Turrini M; Tosi P; Tanasi I; Frigeni M; Grimaldi D; Marchetti M; Norata M; Galimberti S; Fianchi L; Di Veroli A; Ferrara F; Di Bona E; Bono R; Castelli A; Calvisi A; Rivoli G; Molteni A; Nicolino B; Occhini U; Leuzzi L; Genua A; et alii...

2022
AOU Novara

Stefoni V; Zinzani PL; Petrini M; Tisi MC; Tani M; Kovalchuk S; Arcari A; Rosignoli C; Musuraca G; Pozzi S; Cantonetti M; Luzi D; Pane F; D'Alò F; Gini G; Visco C; Margiotta Casaluci G; Cuneo A; Patti C; Stefani PM; Broccoli A; Argnani L; Casadei B;

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.
2021
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Finazzi MC; Tognoni G; Bucelli C; Vianelli N; Bellini M; Scaffidi L; Lunghi F; Betti S; Guglielmelli P; Mannarelli C; Loscocco GG; Mora B; Cacciola E; Cascavilla N; Patriarca A; Siragusa S; Rumi E; Rapezzi D; Musolino C; Caramella M; Carli G; Benevolo G; Pane F; Ricco A; Palandri F; Iurlo A; Ciceri F; Bonifacio M; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Pinto A; Galieni P; Rigacci L; Candoni A; Venditti A; Fava C; Federici AB; Marchesi F; Musto P; Gentile M; Bocchia M; Di Renzo N; Olivieri A; Ferrandina C; Selleri C; Ortu La Barbera E; Luppi M; Scattolin AM; et alii...

Second cancers in MPN: Survival analysis from an international study. in American journal of hematology / Am J Hematol. 2020 Mar;95(3):295-301. doi: 10.1002/ajh.25700. Epub 2019 Dec 22.
2020
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Iurlo A; Cattaneo D; Finazzi G; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Rapezzi D; Erez D; Gomez M; Wille K; Perez-Encinas M; Lunghi F; Angona A; Fox ML; Beggiato E; Benevolo G; Carli G; Barbui T; Vannucchi AM; Rambaldi A; Alvarez-Larran A; De Stefano V; Griesshammer M; et alii...

Delivery of selective internal radiation therapy complicated by variant hepatic vascular anatomy. in Radiology case reports / Radiol Case Rep. 2019 Mar 23;14(6):662-672. doi: 10.1016/j.radcr.2019.03.009. eCollection 2019 Jun.
2019
AOU Novara

Paladini A; Vallati GE; Beomonte Zobel D; Paladini L; Annovazzi A; Sciuto R; Cappelli F; Borzelli A; Pane F; Negroni D; Cernigliaro M; Galbiati A; Del Sette B; Spinetta M; Guzzardi G; Carriero A; Pizzi G;

Successful endovascular treatment of a recurrent giant celiac artery aneurysm. in Radiology case reports / Radiol Case Rep. 2019 Apr 3;14(6):723-728. doi: 10.1016/j.radcr.2019.03.024. eCollection 2019 Jun.
2019
AOU Novara

Borzelli A; Amodio F; Paladini A; de Magistris G; Giurazza F; Silvestre M; Corvino F; Corvino A; Frauenfelder G; Pane F; Coppola M; Zobel DB; Paladini L; Amodeo EM; Cavaglià E; Niola R;

Successful endovascular treatment of a spontaneous bleeding accessory spleen: A case report. in Radiology case reports / Radiol Case Rep. 2019 Apr 12;14(7):787-790. doi: 10.1016/j.radcr.2019.03.037. eCollection 2019 Jul.
2019
AOU Novara

Pane F; Cavaglià E; Silvestre M; Coppola M; Corvino F; Borzelli A; Paladini A; Giurazza F; Corvino A; Zobel DB; Amodio F; Capasso F; Niola R;

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.
2019
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Soverini S; Vigneri P; Rosti G; Russo D; Saglio G; Castagnetti F; Pane F; Breccia M; Bonifacio M; Tomassetti S; Trabacchi E; Spadano R; Tiribelli M; Stagno F; Sancetta R; Sica S; Rege-Cambrin G; Rupoli S; Salvucci M; Rapezzi D; Pregno P; Palmieri F; Musolino C; Miggiano MC; Montefusco E; Melpignano A; Martino B; Marasca R; Lunghi M; et alii...

Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study. in Drug design, development and therapy / Drug Des Devel Ther. 2015 May 18;9:2687-94. doi: 10.2147/DDDT.S79576. eCollection 2015.
2015
AOU Novara

Cascavilla N; De Stefano V; Pane F; Pancrazzi A; Iurlo A; Gobbi M; Palandri F; Specchia G; Liberati AM; D'Adda M; Gaidano G; Fjerza R; Achenbach H; Smith J; Wilde P; Vannucchi AM;

BCR/ABL rearrangement and leukemia phenotype. in Leukemia / Leukemia. 1999 Apr;13 Suppl 1:S96. doi: 10.1038/sj.leu.2401321.
1999
AOU Novara

Saglio G; Pane F; Martinelli G; Guerrasio A;